← Back to Search

Behavioural Intervention

Roadmap to Parenthood Tool for Family Planning After Cancer

N/A

Waitlist Available

Led By Catherine Benedict, PhD

Research Sponsored by Stanford University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

History of a cancer diagnosis

Assigned female at birth

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 12 months

Awards & highlights

Study Summary

This trial will test an online tool to help cancer survivors plan for starting a family after treatment. #familyplanning #cancer

Who is the study for?

This trial is for individuals aged 18-45, assigned female at birth, who have had cancer and are interested in or unsure about having children after treatment. They must understand English, be able to use the internet, and sign a consent form. Those currently in cancer treatment (except long-term therapies like tamoxifen) or with disabilities preventing study participation cannot join.Check my eligibility

What is being tested?

The study is evaluating 'Roadmap to Parenthood,' a web-based tool designed to help those affected by cancer make decisions about family building post-treatment. Participants will either use this tool or receive an informational booklet, with outcomes compared in a randomized controlled trial.See study design

What are the potential side effects?

Since the interventions involve information and planning tools rather than medical treatments, there are no direct physical side effects expected from participating in this trial.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I have been diagnosed with cancer before.

Select...

I was assigned female at birth.

Select...

I am between 18 and 45 years old.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 12 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~12 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Decision Conflict Scale

Secondary outcome measures

Patient-Reported Outcomes Measure-29 (PROMIS-29) Quality of Life

Planning Behaviors for Future Family Building

Other outcome measures

COMRADE subscale

Patient-Reported Outcomes Measure (PROMIS) General Self Efficacy

Patient-Reported Outcomes Measure (PROMIS) General Self-Efficacy and Self-Efficacy for Managing Emotions

+2 more

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Web-based decision support (Roadmap to Parenthood)Experimental Treatment1 Intervention

Patients will receive access to the Roadmap to Parenthood tool (website). The goal of the Roadmap tool is to encourage young adult females (YA-Fs) to be informed about family-building options, set realistic expectations about potential difficulties, and plan ahead to avoid or mitigate barriers, while also inspiring hope and confidence that parenthood may be achieved, despite their cancer histories.

Group II: Informational bookletActive Control1 Intervention

Patients will receive the web-based Livestrong 'Planning for Life After Cancer: A Guide to Survivorship for Teens and Young Adults' informational booklet, covering many topics (e.g., physical symptoms, emotional concerns, day-to-day needs).

0 / 3Eligibility criteria met

Find a Location

Who is running the clinical trial?

National Cancer Institute (NCI)NIH

13,654 Previous Clinical Trials

40,932,897 Total Patients Enrolled

Stanford UniversityLead Sponsor

2,386 Previous Clinical Trials

17,333,752 Total Patients Enrolled

National Institutes of Health (NIH)NIH

2,696 Previous Clinical Trials

6,952,332 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Does this trial have any age restrictions for participation?

"In line with the specified parameters, participants must be between 18-45 years of age to qualify for this clinical trial."

Answered by AI

Do I meet the criteria for participating in this research endeavor?

"Participants should possess a tolerable quality of life and be aged 18-45 to qualify for this clinical trial; 256 individuals will be admitted in total."

Answered by AI

Is the research team currently enrolling participants in this experiment?

"According to the records on clinicaltrials.gov, this medical experiment is not presently recruiting any participants; with its inception date of October 1st 2023 and most recent update dated September 21st 2023. However, there are other 267 studies actively in search for trial volunteers."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Roadmap to Parenthood: Testing the Efficacy of a Decision Aid and Planning Tool for Family Building After Cancer

2024. "Roadmap to Parenthood: Testing the Efficacy of a Decision Aid and Planning Tool for Family Building After Cancer". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT06050135.